SILVER BRIAN M. (Chief Financial Officer) purchased 22.3% of their position (6K shares) of TSCAN THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.2K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/29/2022ACC: 0000899243-22-039506
Officer· Chief Financial Officer
Since Jul 2021
+6K
Net shares
Net buyer
$9.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
6K acquired
Non-Derivative Transactions2
Voting Common Stock
Direct
Shares
+2.84K
Price / share
$1.50
Trade value
$4.28K
% of position
10.6%
12/27/2022
26.89K→29.73K
Voting Common Stock
Direct
Shares
+3.16K
Price / share
$1.56
Trade value
$4.94K
% of position
10.6%
12/28/2022
29.73K→32.88K
Total
Net shares
+6K
Net value
$9.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 12/27/2022 | P · Purchase | +2.84K | $1.50 | $4.28K | 10.6% | 26.89K | 29.73K |
| Voting Common Stock Direct | 12/28/2022 | P · Purchase | +3.16K | $1.56 | $4.94K | 10.6% | 29.73K | 32.88K |
| Total | +6K | $9.22K | ||||||
Derivative Transactions0
No derivative transactions reported